CL
RPRX icon

Choreo LLC’s Royalty Pharma RPRX Stock Holding History

Choreo LLC’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Sell
4,548
-1,007
-18% -$52.4K ﹤0.01% 1407
2026
Q1 		$266K Buy
+5,555
New +$243K ﹤0.01% 1320
2025
Q4 		– Sell
-8,048
Closed -$284K – 1652
2025
Q3 		$284K Buy
8,048
+626
+8% +$22.7K ﹤0.01% 1257
2025
Q2 		$267K Buy
+7,422
New +$246K ﹤0.01% 1255

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Choreo LLC's RPRX Position: Q2 2026 in Review

Choreo LLC reduced its Royalty Pharma (RPRX) stake by 18% in Q2 2026, selling an estimated $52.4K and leaving 4,548 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1407.

Choreo LLC first reported a position in RPRX in Q2 2025 and has held it in 4 quarters since. The position peaked at $284K in Q3 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Choreo LLC held 4,548 shares of Royalty Pharma worth $255K as of Q2 2026.
  • Choreo LLC sold 1,007 Royalty Pharma shares in Q2 2026, an estimated $52.4K.
  • Royalty Pharma made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1407 holding.
  • Choreo LLC first reported a position in Royalty Pharma in Q2 2025 and has held it in 4 quarters since.
  • Choreo LLC's Royalty Pharma position peaked at $284K in Q3 2025.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.